Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ (ORNBV)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
09/14/2018 09/17/2018 09/18/2018 09/19/2018 09/20/2018 Date
30.65(c) 30.75(c) 31.45(c) 31.49(c) 31.83 Last
423 223 247 565 401 184 701 887 295 151 Volume
+0.89% +0.33% +2.28% +0.13% +1.08% Change
More quotes
Financials (EUR)
Sales 2018 991 M
EBIT 2018 288 M
Net income 2018 305 M
Finance 2018 166 M
Yield 2018 4,62%
Sales 2019 1 038 M
EBIT 2019 272 M
Net income 2019 215 M
Finance 2019 127 M
Yield 2019 4,73%
P/E ratio 2018 16,94
P/E ratio 2019 20,48
EV / Sales2018 4,32x
EV / Sales2019 4,16x
Capitalization 4 445 M
More Financials
Company
Orion Oyj engages in the development of pharmaceutical and diagnostic test.It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests.Its pharmaceutical research and development focuses on central nervous system drugs,... 
Sector
Pharmaceuticals
Calendar
09/25Roadshow - Montreal
More about the company
Surperformance© ratings of Orion Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on ORION OYJ
02:33pORION : Changes in responsibility areas of the Orion Group Executive Management ..
AQ
09/19ORION OYJ : Changes in responsibility areas of the Orion Group Executive Managem..
GL
09/17ORION OYJ : Creation of novel medicines and better patient care for the future i..
GL
09/11ORION OYJ : Johanna Ivaska has been appointed Head & Vice President of Oncology ..
AQ
09/11ORION OYJ : Johanna Ivaska has been appointed Head & Vice President of Oncology ..
AQ
09/10ORION OYJ : Johanna Ivaska has been appointed Head & Vice President of Oncology ..
GL
08/17ORION OYJ : Interim report period from January 2018 to June 2018
AQ
07/18ORION OYJ : Group Half-Year Financial Report January-June 2018
GL
07/18ORION OYJ : Corporation's financial reporting and Annual General Meeting in 2019
GL
07/18ORION OYJ : Half-year results
CO
More news
Sector news : Pharmaceuticals - NEC
02:44pONCOMED PHARMACEUTICALS : Says Celgene Won't Exercise Option to License Navicixi..
DJ
02:42pAURORA CANNABIS TARGETING OCTOBER FO : Financial Post
RE
02:36pPFIZER : 20vPnC Vaccine Gets FDA Breakthrough-Therapy Designation
DJ
01:46pNestle aims to shed skin unit to focus on food, nutrition
RE
01:45pNestle aims to shed skin unit to focus on food, nutrition
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
03:14pAustin J. Shanfelter Sells 4,606 Shares of Orion Group Holdings Inc $ORN Stoc.. 
09/19Orion Labs: using "voice super powers" to shake up a legacy industry
3
09/19Systems integration complete on Orion Service Module -  
09/19B. Riley Analysts Increase Earnings Estimates for Orion Group Holdings Inc $O.. 
09/19Systems integration complete on Orion Service Module -
1
More tweets
Qtime:191
News from SeekingAlpha
07/19Orion Corporation OY ADR 2018 Q2 - Results - Earnings Call Slides 
03/26T. Boone Pickens 
03/04WEEKLY COMMENTARY : Cracks 
2017Orion Corporation (ORINF) Investor Presentation - Slideshow 
2017Orion Corporation (ORINF) Investor Presentation - Slideshow 
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 30,9 €
Spread / Average Target -1,8%
EPS Revisions
Managers
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Heikki Seppo Westerlund Chairman
Jari Ilmari Karlson CFO, SVP-Animal Health & IR Contact
Christer Nordstedt Senior Vice President-Research & Development
Sirpa Tuulikki Jalkanen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ1.32%5 192
JOHNSON & JOHNSON0.59%376 820
PFIZER20.13%253 595
NOVARTIS-0.80%216 184
ROCHE HOLDING LTD.-4.06%211 637
MERCK AND COMPANY24.36%186 114